DOC Stock Analysis: Buy, Sell, or Hold?

DOC - Healthpeak Properties, Inc.

REAL ESTATE INVESTMENT TRUSTS
$16.55
-0.04 (-0.24%) β–Ό
5d: -3.61%
30d: -6.39%
90d: +2.73%
HOLD
MODERATE Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: Apr 23, 2026 22d

Get Alerted When DOC Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

πŸ’‘
Bottom Line:
πŸ“Š HOLD: DOC is fairly valued with market pricing in 3.0% annual growth. Fine to hold or accumulate slowly on dips.

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$6.28
Based on 4.7% avg growth
INTRINSIC VALUE TODAY
$3.90
Trading above fair value

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: DOC is currently trading at $16.55, which is considered oversold relative to its 30-day fair value range of $16.89 to $17.56. The stock's valuation (Forward PE: 82.8) is in line with its historical norms (75.7). At these levels, the market is pricing in 3.0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, DOC is showing sideways momentum. The price is currently testing key support at $16.46. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: DOC has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $19.88 (+20.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position OVERSOLD
Fair Price Range $16.89 - $17.56
Company Quality Score 54/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 58.1%

All Signals

  • BULLISH: Price oversold vs 30-day range
  • BEARISH: Weak technical setup (25/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 20.1% below Wall St target ($19.88)
  • NEUTRAL: Market pricing in 3.0% annual earnings growth - fairly valued

Fair Price Analysis

30-Day Fair Range $16.89 - $17.56
Current vs Fair Value OVERSOLD

Support & Resistance Levels

Support Level $16.46
Resistance Level $17.85
Current Trend Sideways
Technical data as of Mar 30, 2026

Fundamental Context

Forward P/E (Next Year Est.) 82.75
Wall Street Target $19.88 (+20.1%)
Revenue Growth (YoY) 3.1%
Earnings Growth (YoY) 2448.4%
Profit Margin 2.5%
Valuation Premium vs History +3.0% premium
PE vs Historical 82.8 vs 75.7 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +3.0% (market-implied from PE analysis)
1-Year Target $17.05 (+3%)
2-Year Target $17.56 (+6%)
3-Year Target $18.08 (+9%)
3-Yr Target (if PE normalizes) (PE: 83β†’76) PE COMPRESSION $16.54 (0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 82.8, Growth: 5.3%) $19.30 (+17%)
Base: (SPY PE: 22.4, Growth: 5.3%) $5.21 (-69%)
Bear: (PE: 19.0, Growth: 5.3%) $4.43 (-73%)
πŸ“ˆ Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (114x PE), but valuation improves significantly next year (83x PE) as earnings recover.
Forward PE: 113.64 | Forward EPS (Implied): $0.15
Bull Case $20.73 (+21%)
Analyst growth 15.0%, PE expands to 119.3
Base Case $17.17 (0%)
Market implied 0.0%, PE stable at 113.6
Bear Case $13.14 (-24%)
Severe decline -15.0%, PE contracts to 102.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: March 31, 2026 1:26 AM ET
Data refreshes hourly during market hours. Next update: 2:26 AM
πŸ”₯ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
1
Buys
1
Sells
0
Net
NEUTRAL
Recent Transactions
Gilbert Ray Cisneros, Jr. SELL 2026-02-10
Gilbert Ray Cisneros, Jr. BUY 2026-01-09

Unlock Insider Activity

See real-time buying/selling by company executives for DOC.

Create Free Account

Already have an account? Log In

Top Rated REIT - Healthcare Facilities Stocks

Top-rated stocks in REIT - Healthcare Facilities by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
VTR
Ventas Inc
STRONG BUY
20 analysts
$92 61 BUY
WELL
Welltower Inc
STRONG BUY
20 analysts
$229 53 HOLD
AHR
American Healthcare REIT…
STRONG BUY
9 analysts
$58 59 HOLD
STRW
Strawberry Fields REIT L…
STRONG BUY
7 analysts
$15 57 HOLD
CTRE
CareTrust REIT Inc.
STRONG BUY
9 analysts
$44 60 HOLD

More Analysis for DOC

DOC Technical Chart DOC Price Prediction DOC Earnings Date DOC Investment Advisor DOC Fair Price Analyzer DOC Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals